66 -5 (55) 2023 — Abdullaeva V.K., Tuychiev Sh.T. — POST COVID-19 SYNDROME: MENTAL AND NEUROLOGICAL DISORDERS

POST COVID-19 SYNDROME: MENTAL AND NEUROLOGICAL DISORDERS

Abdullaeva V.K., Tashkent Pediatric Medical Institute

Tuychiev Sh.T., Tashkent Pediatric Medical Institute

Sultanova K.B., Tashkent Pediatric Medical Institute

Sattarov T.F., Tashkent Pediatric Medical Institute

Rustamova J.T. Tashkent Pediatric Medical Institute

Resume

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the pathogen responsible for the coronavirus disease 2019 (COVID-19) pandemic, which has led to global health impacts and health resource coverage. While identifying the patient population recovering from COVID-19, it is essential to establish an understanding of the health issues surrounding them. COVID-19 is now recognized as a high-spectrum multi-organ disease. Similar to the post-acute viral syndromes described in survivors of epidemics of other virulent coronaviruses, there are increasing reports of persistent and lasting effects after acute COVID-19. Post-acute COVID-19 syndrome with persistent symptoms and/or delayed or severe complications within 4 weeks of illness onset. Here, we present a review of the current literature on post-acute COVID-19, its pathophysiology, and organ-specific sequelae.

Key words: COVID-19, Post COVID-19 syndrome, anxiety, depression, mental complications of COVID-19, neurologic sequels

First page

374

Last page

382

For citation: Abdullaeva V.K., Tuychiev Sh.T., Sultanova K.B.,Sattarov T.F., Rustamova J.T. – POST COVID-19 SYNDROME: MENTAL AND NEUROLOGICAL DISORDERS //New Day in Medicine 2023 5(55): 374-382 https://newdaymedicine.com/index.php/2023/06/12/l-116/

LIST OF REFERENCES:

  1. Dong E., Du H. Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect. 2020 Dis 20, 533-534.
  2. Gupta A. va boshq. Extrapulmonary manifestations of COVID-19. Nat. Med 26, 2020 1017-1032.
  3. Carfi A., Bernabei R., Landi F.   Gemelli. Against COVID-19 Post-Acute Care Study Group. Persistent symptoms in patients after acute COVID-19. J. Am. Med. Assoc 324,  2020 603-605.
  4. Moreno-Pérez O. va boshq. Post-acute COVID-19 syndrome. Incidence and risk factors: a Mediterranean cohort study. J. Infect 10.1016/j.jinf. 2021 01.004.
  5. Halpin S.J. va boshq. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation. J. Med. Virol 93, 2021 1013-1022.
  6. Jacobs L.G. va boshq. Persistence of symptoms and quality of life at 35 days after hospitalization for COVID-19 infection. PLoS ONE 15, e0243882 (2020).
  7. Garrigues E. va boshq. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J. Infect 81, 2020 e4-e6.
  8. Tuychiev Sh., Abdullaeva V., and Matveeva A.. “Prevalence of anxiety and depression among COVID-19 patients: systematic review and meta-analysis” Sciences of Europe, no. 2022 89-1:12-20.
  9. Lee A.M. va boshq. Stress and psychological distress among SARS survivors 1 year after the outbreak. Can. J. Psychiatry 2007 52:233-240.
  10. Huang C. va boshq. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet 397, 2021 220-232.
  11. Sattarov T.F. va boshq. Bolalar va oʻsmirlarda oʻz joniga qasd qilish tendentsiyalarining shakllanishiga ota-onalik uslublarining ta’siri. Human factor Social psychologist, 2023  45(1,):348-353.
  12. Babarahimova S.B., Abdullaeva V.K., Safarboev B.B. Yurak-qon tomir patologiyasi boʻlgan bemorlarda psixologik himoya va kurashish strategiyalari. Inson omili Ijtimoiy psixolog,  2023 45(1):247-253.
  13. Lu R. va boshq. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 395, 2020 565-574.
  14. Hu B., Guo H., Zhou P. Shi Z-L. Characteristics of SARS-CoV-2 and COVID-19. Nat. Rev. Microbiol 19, 2021 141-154.
  15. Shang J. va boshq. Structural basis of receptor recognition by SARS-CoV-2. Nature 581, 2020 221-224.
  16. Wrobel A.G. va boshq. SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects. Nat. Struct. Mol. Biol 27, 2020 763-767.
  17. Needham D.M. va boshq. Physical and cognitive performance of patients with acute lung injury 1 year after initial trophic versus full enteral feeding. EDEN trial follow-up. Am. J. Respir. Crit. Care Med 188, 2013 567-576.
  18. Pandharipande P.P. va boshq. Long-term cognitive impairment after critical illness. N. Engl. J. Med 369, 2013 1306-1316.
  19. Inoue S. va boshq. Post-intensive care syndrome: its pathophysiology, prevention, and future directions. Acute Med. Surg 6, 2019 233-246.
  20. Kress J.P. Hall J.B. ICU-acquired weakness and recovery from critical illness. N. Engl. J. Med 370, 2014 1626-1635.

file

download